Home > Offer to Sell > Pharmaceuticals and Biochemicals > Biochemicals and biotech products > Canagliflozin;JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284

Canagliflozin;JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284

Inquiry
  Post Date: Jan 23,2013
  Expiry Date: Jan 23,2014
  Detailed Description: Cas No. :842133-18-0 Quantity: 1Kilograms

Canagliflozin(JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284) is an experimental drug being developed by Johnson & Johnson for the treatment of type 2 diabetes.Canagliflozin(JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284) is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the urine.
http://www.chemscene.com/Canagliflozin.html

  CAS Registry Number:

842133-18-0
  Synonyms: ;(1s)-1,5-anhydro-1-c-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-methylphenyl)-d-glucitol;1-(β-D-glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienyl-methyl) benzene;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;Canaglifozin;
  Molecular Formula: C24H25FO5S
  Molecular Weight: 444.52
  Molecular Structure: 842133-18-0 canagliflozin

  Company: ChemScene, LLC     [ United States ]        
  Contact: Dr. Gao
  Tel: 732-484-9848
  Fax: 888-484-5008
  Email: information@chemscene.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.